Safety and efficacy of pazopanib in heavily pretreated and treatment-naive patients with metastatic renal cell carcinoma (mRCC): A single center experience of the Medical University of Vienna, Austria.

被引：0
|
作者：
Schmidinger, Manuela
Bojic, Marija
Vogl, Ursula Maria
Klingler, Christoph
Kramer, Gero
Zielinski, Christoph
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[3] Med Univ Vienna, Ctr Canc, Vienna, Austria
[4] Dept Med 1, Div Oncol, Vienna, Austria
[5] Dept Urol, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15090
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience
    Lalani, A-K.
    Li, H.
    Heng, D.
    Wood, L.
    Kalirai, A.
    Bjarnason, G.
    Sim, H-W.
    Kollmannsberger, C. K.
    Kapoor, A.
    Hotte, S. J.
    Vanhuyse, M.
    Czaykowski, P.
    Reaume, M. N.
    Soulieres, D.
    Venner, P.
    North, S.
    Basappa, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Randomized phase II trial of the multi-kinase inhibitor sorafenib versus interferon (IFN) in treatment-naive patients with metastatic renal cell carcinoma (mRCC).
    Escudier, B.
    Szczylik, C.
    Demkow, T.
    Staehler, M.
    Rolland, F.
    Negrier, S.
    Hutson, T. E.
    Scheuring, U. J.
    Schwartz, B.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 217S - 217S
  • [43] Patients (Pts) with Metastatic Renal Cell Carcinoma (mRCC) Receiving Angiogenesis Inhibitor (AI) Therapies: Treatment Efficacy and Safety in Clinical Practice
    McDermott, David
    Choueiri, Toni K.
    Clement, Jessica
    Brick, Ashley J.
    Kwabi, Christabel
    Shah, Karishma
    Antras, Lucia
    Jayawant, Sujata S.
    Wang, Si-Tien
    Luka, Andi
    Duh, Mei Sheng
    Neary, Maureen
    Oh, William K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S111 - S112
  • [44] Efficacy and safety of anlotinib in metastatic renal cell carcinoma: A single-center retrospective study
    Zhu, H.
    Zhou, R.
    Qi, N.
    Zhao, F.
    Li, Z.
    Wang, S.
    Wang, J.
    Chen, R.
    Wen, R.
    EUROPEAN UROLOGY, 2021, 79 : S761 - S761
  • [45] PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC) RECEIVING ANGIOGENESIS INHIBITOR (AIS) THERAPIES: TREATMENT EFFICACY AND SAFETY IN CLINICAL PRACTICE
    McDermott, D.
    Choueiri, T. K.
    Clement, J.
    Brick, A. J.
    Kwabi, C.
    Shah, K.
    Banerjee, A.
    Duh, M. S.
    Neary, M. P.
    Oh, W. K.
    ANNALS OF ONCOLOGY, 2008, 19 : 190 - 191
  • [46] Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan
    Hideaki Miyake
    Ken-ichi Harada
    Masafumi Kumano
    Masato Fujisawa
    International Journal of Clinical Oncology, 2014, 19 : 679 - 685
  • [47] Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan
    Miyake, Hideaki
    Harada, Ken-ichi
    Kumano, Masafumi
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 679 - 685
  • [48] Initial experience with first-line pazopanib in the treatment of metastatic renal cell carcinoma: A single institution data
    Joshi, A.
    Agarwala, V
    Ramaswamy, A.
    Noronha, V
    Patil, V. M.
    Menon, S.
    Popat, P.
    Sable, N.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 575 - 578
  • [49] Clinical evaluation of sunitinib in patients with metastatic renal cell carcinoma: Single center experience
    Karabulut, Senem
    Ekenel, Meltem
    Iribas, Ayca
    Darendeliler, Emin
    Basaran, Mert
    Bevbek, Sevil
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2015, 30 (02): : 51 - 60
  • [50] Experience with first line pazopanib in patients with metastatic renal cell carcinoma in a single tertiary centre: A case series
    Kumarappan, A. L.
    Nasuha, N. A.
    BJU INTERNATIONAL, 2018, 122 : 12 - 12
12345